Last updated: 11 July 2022 at 4:16pm EST

Kristie Wagner Net Worth



Ms. Kristie Wagner biography

Kristie Wagner is the Interim VP & Interim Principal Financial and Accounting Officer at Entasis Therapeutics Inc.



How old is Ms Wagner?

Ms Wagner is 54, she's been the Interim VP & Interim Principal Financial and Accounting Officer of Entasis Therapeutics Inc since . There are 5 older and 2 younger executives at Entasis Therapeutics Inc. The oldest executive at Entasis Therapeutics Holdings Inc is Dr. John Patrick Mueller Ph.D., 61, who is the Chief Devel. Officer.

What's Ms Wagner's mailing address?

Kristie's mailing address filed with the SEC is C/O ENTASIS THERAPEUTICS HOLDINGS INC.,, 35 GATEHOUSE DRIVE, WALTHAM, MA, 02451.

Insiders trading at Entasis Therapeutics Inc

Over the last 6 years, insiders at Entasis Therapeutics Inc have traded over $348,925 worth of Entasis Therapeutics Inc stock and bought 50,891,639 units worth $170,673,776 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Inc.Innoviva Strategic Oppo..., and Holdings A/S Novo. On average, Entasis Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $4,855,580. The most recent stock trade was executed by Inc.Innoviva Strategic Oppo... on 8 July 2022, trading 19,270,476 units of ETTX stock currently worth $42,395,047.



What does Entasis Therapeutics Inc do?

Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis' pathogen-targeted design platform has produced a pipeline of product candidates, including sulbactam-durlobactam (targeting Acinetobacter baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae infections), ETX0282CPDP (targeting Enterobacteriaceae infections) and ETX0462 (targeting Pseudomonas infections).



What does Entasis Therapeutics Inc's logo look like?

Entasis Therapeutics Holdings Inc logo

Entasis Therapeutics Inc executives and stock owners

Entasis Therapeutics Inc executives and other stock owners filed with the SEC include: